2024-11-29 - Analysis Report
## Johnson & Johnson (JNJ) Stock Analysis Report

**1. Performance Comparison & Overview:**

Johnson & Johnson (JNJ) is a multinational pharmaceutical and consumer goods company.  Over the analyzed period, JNJ's cumulative return (37.36%) significantly underperformed the S&P 500 (VOO) return of 128.86%, resulting in a substantial difference of -91.5%.  This places JNJ at the 2.5th percentile of its historical relative performance against the S&P 500, indicating consistent underperformance. The provided alpha values generally hover around 1, suggesting that JNJ's performance has been relatively close to the market, but the negative difference in cumulative return highlights underperformance.  Maximum Drawdown (MDD) has been consistently high, implying substantial risk.

**2. Recent Price Movement:**

* **Closing Price:** $155.4
* **5-day Moving Average:** $154.53
* **20-day Moving Average:** $154.42
* **60-day Moving Average:** $159.33

The price is slightly above the 5 and 20-day moving averages but below the 60-day average, suggesting potential short-term support but a longer-term downtrend.


**3. Technical Indicators & Expected Return:**

* **RSI (49.72):** Near the neutral level of 50, indicating neither overbought nor oversold conditions.
* **PPO (0.28):** Slightly positive, suggesting a potential bullish trend, although weak.
* **Relative Strength Change (20-day):** -3.2%, indicating a recent short-term weakening of relative performance against the benchmark.
* **Expected Return (2+ years):** 0.0%.  Given the historical underperformance against the S&P 500, a long-term investment in JNJ is not expected to generate excess returns over the market. This assumes continued historical patterns.

**4. Recent Earnings Analysis:**

The provided earnings data shows considerable volatility in EPS, with a significant drop in the October 2023 quarter.  Revenue growth is relatively stagnant, showing little significant increase over the last few quarters.  There's no information provided to assess whether these numbers beat or missed expectations.  Analyzing the reported numbers alone, the EPS trend is erratic and revenue growth is flat.

**5. Financial Information Analysis:**

Revenue has remained relatively flat over the past year. Profit margins are consistently high (around 69%), indicating strong profitability despite the flat revenue.  Equity fluctuates, while Return on Equity (ROE) is also highly variable, showing extreme highs and lows suggesting some underlying volatility in the business.  Further investigation into the cause of the massive ROE fluctuation in 2023 Q3 is needed.


**6. News and Recent Issues:**

No news or analyst opinions are provided within the given data.  Therefore, no recent market outlook or analyst opinions can be included.


**7. Overall Analysis:**

JNJ has consistently underperformed the S&P 500 over the analyzed period.  While profit margins remain high, revenue growth is stagnant and EPS fluctuates substantially.  Technical indicators are neutral, suggesting no strong immediate bullish or bearish signals.  The lack of recent news or analyst opinions prevents a full assessment of current market sentiment. The significant underperformance versus the S&P 500, coupled with the high MDD and flat revenue growth raises serious concerns about future returns, especially in comparison to a market index fund.  A long-term investment would require a more thorough analysis beyond the provided data, including an understanding of the underlying causes for the volatile EPS and ROE.


**8. Recommendation:**

Based solely on the provided data, a long-term investment in JNJ is not recommended based on its historical underperformance against the S&P 500. Further research is necessary to address concerns about the volatility in EPS and ROE and to determine if the current valuation is justified.  A comprehensive analysis would need to include:  evaluation of the company's competitive landscape, future growth prospects, and a thorough risk assessment, incorporating factors not included in the current data.
